Cardio-oncology & otherMeta-analysis

Association between cardiovascular disease and risk of female sexual dysfunction: a systematic review and meta-analysis

Eur J Prev CardiolPublished

  • Systematic review and meta-analysis of observational studies
  • random-effects models
  • Newcastle-Ottawa Scale quality assessment
  • Databases searched from inception to 28 February 2023

Authors' conclusion

Our meta-analysis indicated that patients with CVD suffer from a greater risk of developing FSD.

Study context

Population
Women with or without cardiovascular diseases (CVD); studies reporting the risk of female sexual dysfunction (FSD)54 articles
Participants
148,946 women
Comparison
CVD vs no CVD
Outcome
Female sexual dysfunction (FSD)

Pooled result

FSD

Odds ratio

1.51

95% CI 1.34–1.69

P < 0.001

CVD vs Control
OR 1.51 (95% CI 1.34–1.69); P < 0.001

As reported in the abstract

Further pooled results

OutcomeEstimateP value
FSD, longitudinal studies (subgroup) · heterogeneity I2 = 86.7%, P < 0.001RR 1.50 (95% CI 1.21–1.86)P < 0.001
FSD by condition: hypertension, stroke, myocardial infarction — hypertension vs Control · heterogeneity I2 = 82.7%, P < 0.001OR 1.41 (95% CI 1.23–1.62)P < 0.001
FSD by condition: hypertension, stroke, myocardial infarction — stroke vs Control · heterogeneity I2 = 0%, P < 0.423OR 1.81 (95% CI 1.54–2.12)P < 0.001
FSD by condition: hypertension, stroke, myocardial infarction — myocardial infarction vs Control · heterogeneity I2 = 82.4%, P < 0.001OR 2.07 (95% CI 1.60–2.67)P < 0.001

Sources of heterogeneity (meta-regression)

Primary sources of heterogeneity attributable to adjustments for covariates, study design and study population

Original publication

Association between cardiovascular disease and risk of female sexual dysfunction: a systematic review and meta-analysis. Eur J Prev Cardiol. Published 31 January 2024. doi:10.1093/eurjpc/zwae042

Summarised from the published abstract; every number is checked against it